- Acute MI:
- 18mg (10 units) IV bolus given over 2 minutes, then second dose given 30 minutes after first
Injection: 18mg/10mL
- Stable for 4 hours at room temp
Thrombolytic
It binds to fibrin and converts tissue plasminogen to plasmin, promoting fibrinolysis
- Bleeding
- Hypersensitivity
- Active bleeding
- Recent CVA (within 3 months)
- Recent intracranial or intraspinal surgery or trauma (within 3 months)
- Intracranial neoplasm
- AVM
- Aneurysm
- Bleeding diathesis
- Severe uncontrolled hypertension
- Mifepristone
- Human prothrombin complex concentrate
Drug Status
| Availability | Prescription only |
| Pregnancy | Category C |
| Breastfeeding | Unlikely to be b/feeding at indicated circumstances |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Mirel | 18mg/10mL | Injection | 1’s | Galaxy Pharma | Galaxy Pharma |